Charlotte’s Web Earns U.S. Patent For Improved Hemp Variety

Charlotte’s Web, a producer and distributor of hemp-derived CBD wellness products, has earned U.S. utility patent U.S. 10,653,085, its second U.S. patent for hemp genetics. This patent is for ‘CW1AS1’, a new hemp variety created by Joel Stanley, company co-founder, and Bear Reel, senior director of cultivation R&D. The patent takes Charlotte’s Web’s premier proprietary genetics to the next generation, and builds a strong wall of protection around it, and the products made from it.

“This ‘CW1AS1’ patent gives Charlotte’s Web the highest level of protection for our proprietary genetics and ensures that Charlotte’s Web products will continue to be available to the thousands who use them in a form that is consistent and provides the same user experience time and time again,” said Deanie Elsner, Charlotte’s Web CEO and president.

Patents on hemp genetics are a new frontier, and very few patents in this sector have been issued to date. Charlotte’s Web, the world’s largest vertically integrated hemp company, has been at the forefront of this new frontier in hemp patents and will continue to invest in its breeding program and in the science of hemp to ensure a consistent and high-quality supply is available.

“This patent recognizes the progress our breeding program has made to assure our farmer partners that the plants they grow will yield better and have a high level of phytocannabinoids,” said Reel.

Charlotte’s Web’s flagship Original Formula was the first CBD wellness product to be sold nationally to consumers. Before Charlotte’s Web was officially founded in 2013, there was a waiting list of more than 15,000 individuals for Original Formula, which uses the same proprietary phytochemical profiles produced by the now patented ‘CW1AS1’ hemp variety.